Simulate first, then a human deploys. LIFE OS never deploys on its own.
Interventions
Synthetic demo data
What is working in this population
Outcomes of every action among the 42 patients matching “eligible for NP-02 · confidence ≥ 70%”. Sorted by evidence weight (n × improved share).
| Action | n | Improved | Mean effect | Onset | |
|---|---|---|---|---|---|
| ME-01 Monitoring Escalation | 15 | 100% | −3% | 3 d | Simulate |
| SC-12 Supportive Compound | 9 | 89% | −16% | 6 d | Simulate |
| GI-04 GI Support Protocol | 15 | 53% | −14% | 8 d | Simulate |
| CR-01 Clinician Review | 2 | 100% | −9% | 5 d | Simulate |
Create intervention
- Cohort
- 42 patients · eligible for NP-02 · confidence ≥ 70%
Enforcement in the companion
Before deployment
simulationCampaigns
Nothing deployed yet in META-24.
Action catalogue
GI-04Nutritional protocol
GI Support Protocol GI-04
symptom −31% · persistence +17% · onset 8 d
SC-12Supportive compound
Supportive Compound SC-12
symptom −18% · persistence +11% · onset 6 d
NP-02Nutritional protocol
Dietary Support Protocol NP-02
symptom −28% · persistence +9% · onset 10 d
HY-01Hydration protocol
Hydration Protocol HY-01
symptom −14% · persistence +6% · onset 4 d
ME-01Monitoring escalation
Monitoring Escalation ME-01
symptom −5% · persistence +12% · onset 3 d
BR-03Behavioural recommendation
Behavioural Recommendation BR-03
symptom −10% · persistence +10% · onset 7 d
CR-01Clinician review
Clinician Review CR-01
symptom −12% · persistence +15% · onset 5 d
AD-05Adherence support
Adherence Support AD-05
symptom −2% · persistence +14% · onset 5 d
DT-01Dosing / timing recommendation
Dosing / Timing Recommendation DT-01
symptom −16% · persistence +8% · onset 5 d